Multiple conformational states in retrospective virtual screening - Homology models vs. crystal structures: Beta-2 adrenergic receptor case study

Journal of Cheminformatics

Volumn 7, Issue 1, 2015, Pages

  Mordalski, Stefan ^a   Witek, Jagna ^a   Smusz, Sabina ^a,b   Rataj, Krzysztof ^a   Bojarski, Andrzej J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Crystal structures; Ensemble of receptors; Homology models; Structural Interaction Fingerprints; Virtual screening

Indexed keywords

EID: 84928792265     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/s13321-015-0062-x     Document Type: Article

References (31)

1. Klabunde T, Hessler G. Drug design strategies for targeting G-protein-coupled receptors. ChemBioChem. 2002;3(10):928-44.
2. Lagerström MC, Schiöth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7(4):339-57.
3. Lundstrom K. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods Mol Biol. 2009;552:51-66.
4. Liggett SB. Molecular and genetic basis of beta2-adrenergic receptor function. J Allergy Clin Immunol. 1999;104(2 Pt 2):S42-6.
5. McGraw DW, Liggett SB. Molecular mechanisms of beta2-adrenergic receptor function and regulation. Proc Am Thorac Soc. 2005;2:292-6. discussion 311-312.
6. Kolb P, Rosenbaum DM, Irwin JJ, Fung JJ, Kobilka BK, Shoichet BK. Structure-based discovery of beta2-adrenergic receptor ligands. Proc Natl Acad Sci USA. 2009;106:6843-8.
7. Strosberg AD. Structure, function, and regulation of adrenergic receptors. Protein Sci. 1993;2(8):1198-209.
8. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007;318(5854):1258-65.
9. Deng Z, Chuaqui C, Singh J. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. J Med Chem. 2004;47(2):337-44.
10. Witek J, Smusz S, Rataj K, Mordalski S, Bojarski AJ. An application of machine learning methods to structural interaction fingerprints - a case study of kinase inhibitors. Bioorg Med Chem Lett. 2014;24(2):580-5.
11. Rataj K, Witek J, Mordalski S, Kosciolek T, Bojarski AJ. Impact of template choice on homology model efficiency in virtual screening. J Chem Inf Model. 2014;54(6):1661-8.
12. Rasmussen SGF, Choi H-J, Fung JJ, Pardon E, Casarosa P, Chae PS, et al. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature. 2011;469(7329):175-80.
13. Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, et al. Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature. 2011;469(7329):236-40.
14. Tang H, Wang XS, Hsieh JH, Tropsha A. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? Proteins. 2012;80(6):1503-21.
15. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucl Acids Res. 2011;40(Database issue):D1100-7.
16. Canvas, version 1.3, Schrödinger, LLC, New York, NY, 2010.
17. Huang N, Shoichet BK, Irwin JJ. Benchmarking sets for molecular docking. J Med Chem. 2006;49(23):6789-801.
18. Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177-82.
19. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779-815.
20. LigPrep, version 2.5, Schrödinger, LLC, New York, NY, 2011.
21. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: an update. SIGKDD Explorations. 2009;11:10-8.
22. Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20:273-97.
23. Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013;340(6132):610-4.
24. Wacker D, Wang C, Katritch V, Han GW, Huang X-P, Vardy E, et al. Structural features for functional selectivity at serotonin receptors. Science. 2013;340(6132):615-9.
25. Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao Z-G, et al. Structure of an agonist-bound human A2A adenosine receptor. Science. 2011;332(6027):322-7.
26. Warne T, Moukhametzianov R, Baker JG, Nehmé R, Edwards PC, Leslie AGW, et al. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature. 2011;469(7329):241-4.
27. Wu B, Chien EYT, Mol CD, Fenalti G, Liu W, Katritch V, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010;330(6007):1066-71.
28. Chien EYT, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science. 2010;330(6007):1091-5.
29. Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475(7354):65-70.
30. Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482(7386):547-51.
31. Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E, et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature. 2012;6027:552-6.